• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

4

CATEGORIES

  • 23
  • 21
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1

PRICE

0
5
8
58

PUBLISHED

2
3
30
58

PRODUCT TYPE

50
8

Search "Upsher-Smith Laboratories, Inc.-Detailed Product Pipeline" returned 58 results.

Upsher-Smith Laboratories, Inc. - Product Pipeline Review - 2014

Upsher-Smith Laboratories, Inc. - Product Pipeline Review - 2014 Summary “Upsher-Smith Laboratories, Inc. - Product Pipeline Review - 2014” provides data on the Upsher-Smith Laboratories, Inc.’s...

January 2014
FROM

Upsher-Smith Laboratories, Inc. - Product Pipeline Review - 2013

Upsher-Smith Laboratories, Inc. - Product Pipeline Review - 2013 Summary “Upsher-Smith Laboratories, Inc. - Product Pipeline Review - 2013” provides data on the Upsher-Smith Laboratories, Inc.’s...

June 2013
FROM
Upsher-Smith Laboratories, Inc. - Product Pipeline Review - 2012 Upsher-Smith Laboratories, Inc. - Product Pipeline Review - 2012 - Product Thumbnail Image

Upsher-Smith Laboratories, Inc. - Product Pipeline Review - 2012

Upsher-Smith Laboratories, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Upsher-Smith Laboratories, Inc. - Product Pipeline Review - 2012” provides...

November 2012
FROM
Upsher-Smith Laboratories, Inc. - Product Pipeline Review - Q4 2010 Upsher-Smith Laboratories, Inc. - Product Pipeline Review - Q4 2010 - Product Thumbnail Image

Upsher-Smith Laboratories, Inc. - Product Pipeline Review - Q4 2010

Upsher-Smith Laboratories, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Upsher-Smith Laboratories, Inc.- Product Pipeline Review - Q4 2010” provides...

November 2010
FROM

Upsher-Smith Laboratories, Inc. - Product Pipeline Review - Q4 2010

Upsher-Smith Laboratories, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Upsher-Smith Laboratories, Inc.- Product Pipeline Review - Q4 2010” provides...

November 2010
FROM

Type 2 Diabetes - Pipeline Review, H2 2014

Type 2 Diabetes - Pipeline Review, H2 2014 Summary This, ‘Type 2 Diabetes - Pipeline Review, H2 2014’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Seizures - Pipeline Review, H1 2015

Seizures - Pipeline Review, H1 2015 Summary This, ‘Seizures - Pipeline Review, H1 2015’, provides an overview of the Seizures’s therapeutic pipeline. This report provides comprehensive information...

January 2015
FROM

Seizures - Pipeline Review, H2 2014

Seizures - Pipeline Review, H2 2014 Summary This, ‘Seizures - Pipeline Review, H2 2014’, provides an overview of the Seizures’s therapeutic pipeline. This report provides comprehensive information...

November 2014
FROM

Inflammatory Pain - Pipeline Review, H1 2014

Inflammatory Pain - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Inflammatory Pain - Pipeline Review, H1 2014’, provides an overview of the Inflammatory Pain’s therapeutic pipeline. This...

February 2014
FROM

Psoriasis - Pipeline Review, H1 2014

Psoriasis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H1 2014’, provides an overview of the Psoriasis’s therapeutic pipeline. This report provides comprehensive...

February 2014
FROM

Global Osteoporosis Drugs Market 2015-2019

About osteoporosis Osteoporosis, or porous bone, is a disease characterized by low bone density and structural deterioration of bone tissue, leading to fragile bones. As bones becomes fragile, risk...

May 2015
FROM

Obesity - Pipeline Review, H2 2014

Obesity - Pipeline Review, H2 2014 Summary This, ‘Obesity - Pipeline Review, H2 2014’, provides an overview of the Obesity’s therapeutic pipeline. This report provides comprehensive information on...

September 2014
FROM

Dyskinesia - Pipeline Review, H1 2014

Dyskinesia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Dyskinesia - Pipeline Review, H1 2014’, provides an overview of the Dyskinesia’s therapeutic pipeline. This report provides...

March 2014
FROM

Obesity - Pipeline Review, H1 2015

Obesity - Pipeline Review, H1 2015 Summary This, ‘Obesity - Pipeline Review, H1 2015’, provides an overview of the Obesity’s therapeutic pipeline. This report provides comprehensive information on...

February 2015
FROM

Alzheimer's Disease - Pipeline Review, H2 2014

Alzheimer's Disease - Pipeline Review, H2 2014 Summary This, ‘Alzheimer's Disease - Pipeline Review, H2 2014’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline. This report...

October 2014
FROM

Psoriasis - Pipeline Review, H2 2014

Psoriasis - Pipeline Review, H2 2014 Summary This, ‘Psoriasis - Pipeline Review, H2 2014’, provides an overview of the Psoriasis’s therapeutic pipeline. This report provides comprehensive information...

October 2014
FROM

Dermatitis - Pipeline Review, H1 2015

Dermatitis - Pipeline Review, H1 2015 Summary This, ‘Dermatitis - Pipeline Review, H1 2015’, provides an overview of the Dermatitis’s therapeutic pipeline. This report provides comprehensive information...

March 2015
FROM

Epilepsy - Pipeline Review, H1 2015

Epilepsy - Pipeline Review, H1 2015 Summary This, ‘Epilepsy - Pipeline Review, H1 2015’, provides an overview of the Epilepsy’s therapeutic pipeline. This report provides comprehensive information...

January 2015
FROM

Epilepsy - Pipeline Review, H1 2014

Epilepsy - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H1 2014’, provides an overview of the Epilepsy’s therapeutic pipeline. This report provides comprehensive...

February 2014
FROM

Seizures - Pipeline Review, H1 2014

Seizures - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Seizures - Pipeline Review, H1 2014’, provides an overview of the Seizures’s therapeutic pipeline. This report provides comprehensive...

June 2014
FROM
Loading Indicator

Our Clients

Goodyear Tire & Rubber Company GlaxoSmithKline PLC Hilton Worldwide Hewlett-Packard Company Accenture PLC. Qualcomm Incorporated UBS AG